Omada Health Earns Buy Rating, $30 Target as Profitability Nears

BTIG Research initiated coverage on Omada Health, Inc. with a Buy rating. The firm established a price target of $30 per share.

Analysts expect the digital healthcare company to reach profitability within the current year. Multiple analysts have recently increased their earnings estimates for the company.

Omada Health utilizes a value-based care model where it receives payment based on member usage. BTIG identifies this payment structure as a competitive advantage in the evolving healthcare market.